Parmjot Bains , MBChB, M Phil, CEO at ImpediMed, recently shared with?Healthcare IT Today?how MedTech innovations are setting a new standard for population health.?? ? By leveraging Bioimpedance Spectroscopy (BIS) technology, healthcare providers can now catch conditions like lymphedema early, offering more precise, proactive interventions for cancer survivors.? ? “By moving beyond traditional methods, tools like BIS empower us to deliver earlier, targeted interventions that significantly improve patient outcomes,” Parmjot explains.? ? Discover how we’re working to make these advancements accessible for all: https://lnkd.in/euZkVwF3 ? #HealthcareInnovation #LymphedemaAwareness #DigitalHealth #PatientOutcomes #PopulationHealth?
关于我们
ImpediMed Limited is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm and leg in female and male cancer patients.
- 网站
-
https://www.impedimed.com
ImpediMed的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- Carlsbad,CA
- 类型
- 上市公司
- 创立
- 1999
- 领域
- Lymphedema、Fluid Status、Body Composition、Tissue Analysis、Breast Cancer和Heart Failure
地点
ImpediMed员工
-
Steven Chen, MD, MBA
Surgical Oncologist | Chief Medical Officer | Biotechnology | Medical Device
-
Aaron Ogilvie
-
Richard Hines
Senior Manager of Regulatory Affairs
-
Amy Beth Gerzog
Always committed to empowering medical professionals to make smarter purchasing decisions without sacrificing patient care. Passion for animals, our…
动态
-
Exciting News! We are proud to announce that the NAPBC has officially included bioimpedance spectroscopy (BIS) in its breast cancer survivorship guidelines! ImpediMed's SOZO? platform is helping revolutionize lymphedema prevention for breast cancer survivors. Stay tuned for more updates on how we’re making a difference! ?? https://ow.ly/WkyM50UclbQ #BreastCancerAwareness #SOZO #LymphoedemaAwareness #SurvivorshipCare #BCRL
-
Meet Sabrina Korentager, MSN, BS, RN, CLT-UE, a trailblazing oncology nurse and Co-Founder of the Lymphedema Prevention Program at The University of Kansas Cancer Center. Sabrina’s passion for early lymphedema detection started with a powerful conversation with a cancer survivor and has since grown into a comprehensive program transforming patient care. Through her work, Sabrina is ensuring that breast cancer-related lymphedema (BCRL) is no longer just a side effect to be watched and waited for but a condition that can be proactively managed and prevented. Her insights into patient-centered, at-home care and lymphedema surveillance are changing the way we support cancer survivors. ?? Learn more about Sabrina’s inspiring journey and her impact on cancer care: https://lnkd.in/gdeGW2gh #LymphedemaAwareness #SurvivorshipCare #EarlyDetectionMatters
5 questions with oncology nurse, co-founder of Lymphedema Prevention Program
healio.com
-
It’s been an incredible week connecting with experts and discussing proactive care across women’s health! We’re excited to wrap it up at the Magee-Womens Summit in Pittsburgh earlier today, where leaders in research, clinical care, and policy came together to transform the future of women’s health. At ImpediMed, we’re proud to share our commitment to early detection and prevention, including programs like our Lymphedema Prevention Program, which empowers breast cancer survivors to take charge of their long-term health. Here’s to advancing women’s health through collaboration and innovation! Learn more about our LPP: https://ow.ly/ECqo50U7yMX #MageeSummit #WomensHealth #ProactiveCare #LymphedemaPrevention
Lymphedema Prevention Program
impedimed.com
-
A Million Milestones Achieved with SOZO! This month, we celebrate an incredible achievement: over 1 million tests completed with our SOZO? Digital Health Platform! Each test reflects our commitment to proactive lymphedema care, early detection, and setting new standards in survivorship. SOZO is more than technology; it’s a core part of our Lymphedema Prevention Program (LPP), which empowers patients with evidence-based care designed to support better health outcomes. Ready to join the million others benefiting from SOZO’s impact? Learn more about the LPP and how we’re reshaping survivorship care: https://ow.ly/Ax9f50U6m0K #LymphedemaPrevention #SurvivorshipCare #BioimpedanceSpectroscopy #SOZO
-
?? Groundbreaking News in Breast Cancer Care! The NAPBC now includes bioimpedance spectroscopy (BIS) in its updated standards for breast cancer survivorship care. Our SOZO? platform is the only FDA-cleared BIS solution for lymphedema assessment, and is leading the charge in early lymphedema detection, empowering patients and healthcare providers. We’re proud to be part of this journey toward improved survivorship. Learn more: https://ow.ly/5xr050U5NAM. #BreastCancerAwareness #Lymphoedema #Survivorship #BIS #NAPBC
NAPBC Standards | ImpediMed
impedimed.com
-
We’re incredibly proud to share that Parmjot Bains , MBChB, M Phil, ImpediMed’s Managing Director and CEO, has been recognized with a Silver Stevie Award for Women in Business! ?? This award celebrates her outstanding leadership in healthcare and her commitment to early detection and prevention for breast cancer survivors facing lymphedema. Parmjot’s vision is driving meaningful change and setting new standards in patient care. Congratulations, Parmjot, on this remarkable achievement—you continue to inspire us all! #StevieAwards #WomenInBusiness #HealthcareLeadership #LymphedemaAwareness
-
Our busy week of provider engagement continues! Next up: AAPM&R’s 2024 Annual Assembly in sunny San Diego. We’re joining leaders in physical medicine and rehabilitation to explore the latest advancements in patient care, including the role of early detection for better outcomes in lymphedema management. With a focus on proactive care and improved patient outcomes, we’re excited to connect and share insights on supporting rehabilitation goals. Want to see early detection in action? Schedule a demo today: https://ow.ly/wRGX50U2LbH #AAPMR24 #PhysicalMedicine #RehabInnovation #Lymphedema #EarlyDetection
-
We’re excited to kick off a busy week of provider engagement with the 2024 AONN+ Annual Conference from November 5-7 in Las Vegas! Our team will be on-site, ready to connect and share insights with leaders in patient navigation, breast cancer care, and women’s health. This week, we’re diving into discussions around early detection and prevention of lymphedema—critical steps in transforming the care continuum and supporting better outcomes for patients everywhere. If you're attending, don’t miss the chance to connect with our team to learn more about ImpediMed’s commitment to proactive, patient-centered care. Want to know more? Schedule a demo to see how early lymphedema detection can change the patient journey: https://ow.ly/ZJSY50U1Huy #AONN2024 #HealthcareInnovation #EarlyDetection #LymphedemaPrevention
-
Thank you to Physician's Weekly for sitting down with our CMO, Steven Chen, MD, MBA, to discuss the importance of whole-person health in managing breast cancer-related lymphedema. Learn how early detection and specialist collaboration can make a difference.? ? ??? Listen by clicking the link below!?
For breast cancer awareness month, Steven Chen, MD, MBA, CMO of ImpediMed, highlights the value of whole-person health in managing breast cancer-related lymphedema, emphasizing differences from traditional care, cost barriers, patient education, early detection, long-term side effects, and the importance of specialist collaboration. Tune in here: https://buff.ly/3NznwlP